Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Gabapentin

Is Gabapentin legal in Ireland?

Also known as: neurontin

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Not a controlled drug in Ireland. The placement recorded for this row is: No controlled-drug schedule; 2010 Act s. 2(1)(a). The wording relied on is “This Act shall not apply to... a medicinal product”, and it is an exclusion or a statutory test rather than a listing. Gabapentin is absent from all five schedules and its medicinal-product presentation is expressly outside the 2010 Act. Two separate things are recorded here, an absence from Schedules 1 to 5 and a statutory exclusion from the 2010 Act, and the exclusion is tied to the qualifying presentation rather than to the chemical in every form it might take. This row and the dextromethorphan row cite the same provision and are given opposite ceilings, and the source read does not settle it. Both name section 2(1)(a) of the 2010 Act, the medicinal product exclusion. This row treats it as closing the 2010 Act route for the qualifying product. The dextromethorphan row keeps a conditional section 1 and section 3 route open on the same subsection. Nothing in either row explains the difference and no side is taken here.
Consequences if caught
Capital exposure: none. Ireland has no death penalty, so nothing on this row can reach one. The exposure that runs is not a Misuse of Drugs Act exposure at all, because the placement recorded for this row reads: No controlled-drug schedule; 2010 Act s. 2(1)(a). No ceiling under the Misuse of Drugs Act 1977 attaches to this row, because that Act reaches only a controlled drug. The 2010 Act route is blocked as well for the qualifying product, because the section 2 exclusion recorded for this row takes it outside that Act rather than merely failing to catch it. An exclusion is tied to the qualifying presentation and does not travel with the chemical into some other form. The source's own ceiling line for this row reads: No 1977 Act controlled-drug ceiling attaches to gabapentin; the stated section 2 exclusion prevents the 2010 Act route for the qualifying product. Read as at 20 September 2026. These are the statutory ceilings the source records and they are not a prediction of what any court would impose.
If prescribed or medical
Not established for Ireland in the source read here, and deferred rather than guessed. The dossier this cell was authored from carries no prescription column and no traveller column, and no source for one, so nothing is asserted about whether a visitor may bring gabapentin into Ireland, what a foreign prescription is worth at an Irish border, or what licence, certificate or authorisation Ireland requires for it. That was not researched and it is not inferred here. What the row does establish is its placement, which reads: No controlled-drug schedule; 2010 Act s. 2(1)(a). Attached to this substance, the wording read for it is “This Act shall not apply to... a medicinal product”, and that is a scheduling record rather than anything about medicine. What this row's own words do say is that a medicinal product is outside the 2010 Act. That is an exclusion from a criminal statute and it is not a prescribing route, a licence or a permission to import anything. A scheduling fact is not a prescribing route, and the silence in this field is an absence of research rather than a permission.
Documentation
Carry the product's own labelling and full ingredient list, because the analysis on this row turns on what the product actually is and not on what it is called, and the source read here establishes no placement in the controlled-drug schedules for gabapentin to be identified against. Provenance: the placement relied on reads: No controlled-drug schedule; 2010 Act s. 2(1)(a). It was checked on 20 September 2026. What was actually read is “This Act shall not apply to... a medicinal product”, and nothing beyond that wording is carried here. The dossier behind this cell supplied no address for this row, so the citation carried here is to the named instrument and not to a retrieved document.
Primary sources
  • Ireland. The governing statute is the Misuse of Drugs Act 1977, and the provisions this row relies on are the ones printed in its own recorded lines below, with none added to them. This row names no statutory instrument at all. It rests on what its own line records rather than on a regulation, so no instrument number is given here and none has been added to it. The instrument and section string recorded in full for gabapentin is: No controlled-drug schedule
  • 2010 Act s. 2(1)(a)
  • row-specific search for gabapentin (gabapentin). The entry or wording read is “This Act shall not apply to... a medicinal product”, quoted here as the dossier prints it. The exact search recorded against that instrument is: "gabapentin" / "gabapentin" in the instrument named in column 3. The ceiling and the provision carrying it are recorded as: No 1977 Act controlled-drug ceiling attaches to gabapentin
  • the stated section 2 exclusion prevents the 2010 Act route for the qualifying product. Read as at 20 September 2026. The second statute is named in the dossier only as the 2010 Act, with no short title given, so it is cited here in the dossier's own words and no title has been supplied for it. No address is given here because the dossier supplied none. Its address column carried only the words "Source 1Source 2" for this row, and no address of any kind appears anywhere in the dossier, so this citation is to the named instrument rather than to a retrieved document. Nothing has been supplied in place of the missing address.

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Gabapentin in related jurisdictions

Other substances confirmed in Ireland

Same substance, other countries